A decreasing trend in IL-6 values in patients during sepsis follow-up is thought to be associated with a better prognosis in sepsis (Kumar et al. 2009 ).
← all excerpts
The impact of tocilizumab treatment on the severity of inflammation and survival rates in sepsis is significantly influence by the timing of administration.
1
—
—